☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Top Performing Drug of 2021 – Eylea (September Edition)
September 22, 2022
AstraZeneca and Merck’s Lynparza (olaparib) Receive NMPA’s Approval as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian...
September 22, 2022
Biogen Publishes P-III (VALOR) Study Results of Tofersen for the Treatment of Amyotrophic Lateral Sclerosis at NEJM
September 22, 2022
GSK Entered into an Exclusive License Agreement with Spero Therapeutics for Tebipenem HBr to Treat Urinary Tract Infections
September 22, 2022
Eli Lilly's Retevmo (selpercatinib) Receives the US FDA’s Approval for Advanced or Metastatic Solid Tumors with a RET Gene Fusion
September 22, 2022
Abpro Collaborated with Celltrion to Develop and Commercialize ABP 102 for the Treatment of HER2+ Cancer
September 22, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions